SCHEMBL20130972

SCHEMBL20130972

c1ccc(-c2c3ccc(N(c4ccccc4)c4ccccc4)cc3c(-c3ccc(-c4ccc5cc(-c6c7ccc(N(c8ccccc8)c8ccccc8)cc7c(-c7ccc8ccccc8c7)c7ccc(N(c8ccccc8)c8ccccc8)cc67)ccc5c4)cc3)c3ccc(N(c4ccccc4)c4ccccc4)cc23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 7/20 0.41
ESR2 Q92731 7/20 0.41
HSD17B1 P14061 2/20 0.38
HSD17B2 P37059 2/20 0.38
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2B6 P20813 1/20 0.38
CYP2C19 P33261 1/20 0.38
ACMSD Q8TDX5 1/20 0.37
ALOX5 P09917 2/20 0.36
PTGES O14684 1/20 0.36
CYP17A1 P05093 1/20 0.36
CYP19A1 P11511 1/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
BACE1 P56817 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14099672 0.99 ESR1 (0.41) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL12337349 0.99 ESR1 (0.39) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL14099685 0.99 ESR1 (0.39) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL19621666 0.99 ESR1 (0.39) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL14100085 0.97 ESR1 (0.40) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL13333560 0.97 ESR1 (0.40) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL13333898 0.97 ESR1 (0.38) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL13333738 0.97 ESR1 (0.40) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL12928333 0.97 ESR1 (0.37) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL15762773 0.97 ESR1 (0.39) ESR1ESR2HSD17B1HSD17B2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190319197-A1 ORGANIC COMPOUND, APPLICATIONS THEREOF, ORGANIC MIXTURE, AND ORGANIC ELECTRONIC DEVICE GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) 2019-10-17 US disclosed
US-20180130955-A1 ORGANIC COMPOUND, MIXTURE COMPRISING SAME, COMPOSITE, AND ORGANIC ELECTRONIC COMPONENT GUANGZHOU CHINARAY OPTOELECTRONICS MATERIALS LTD. (CN) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130955-A1 ORGANIC COMPOUND, MIXTURE COMPRISING SAME, COMPOSITE, AND ORGANIC ELECTRONIC COMPONENT OCIAD1, OCIAD2, SRD5A1 ESR1 48/4885ESR2 58/4885HSD17B1 1220/4885
US-20190319197-A1 ORGANIC COMPOUND, APPLICATIONS THEREOF, ORGANIC MIXTURE, AND ORGANIC ELECTRONIC DEVICE PIEZO1, OR10J3, OR51E2 ESR1 33/4885ESR2 153/4885HSD17B1 629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.